Hollow glass microspheres offer numerous functional advantages for biopharmaceuticals. These tiny spherical particles can be derived from a growing range of organic and inorganic materials, making them an extremely versatile solution for novel drug delivery systems.
Further research and development (R&D) into new compositions continues to create new opportunities for microsphere technology deployment.
Researchers have generated porous or hollow glass microspheres to enhance their drug-carrying capacity. Such hollow glass microspheres have been used to protect fragile drug compounds in vivo and to extend their bioavailability. There have also been many strides forward with biodegradable polymer hollow glass microspheres for controlled drug delivery.
The growing availability of highly tunable hollow glass microspheres has significant ramifications for treating numerous conditions, including embolisation therapy, lipoatrophy in AIDS patients, stress urinary incontinence (SUI) treatment), and so on. Microsphere technology is also of growing importance in precision medicine and targeted therapies for cancer and cardiovascular disease. The future of microsphere technology is bright.
